International Journal of Endocrinology and Metabolism

Published by: Kowsar

Association of Mean Platelet Volume With Androgens and Insulin Resistance in Nonobese Patients With Polycystic Ovary Syndrome

Bercem Aycicek Dogan 1 , * , Ayse Arduc 2 , Mazhar Muslum Tuna 1 , Ersen Karakılıc 1 , Iffet Dagdelen 1 , Yasemin Tutuncu 1 , Dilek Berker 1 and Serdar Guler 1
Authors Information
1 Ankara Numune Training and Research Hospital, Endocrinology and Metabolism Disease, Ankara, Turkey
2 National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes-Endocrine and Obesity Branch, National Institutes of Health, Bethesda, Maryland, USA
Article information
  • International Journal of Endocrinology and Metabolism: October 01, 2014, 12 (4); e18642
  • Published Online: October 1, 2014
  • Article Type: Research Article
  • Received: March 2, 2014
  • Revised: April 13, 2014
  • Accepted: May 17, 2014
  • DOI: 10.5812/ijem.18642

To Cite: Aycicek Dogan B, Arduc A, Muslum Tuna M, Karakılıc E, Dagdelen I, et al. Association of Mean Platelet Volume With Androgens and Insulin Resistance in Nonobese Patients With Polycystic Ovary Syndrome, Int J Endocrinol Metab. 2014 ;12(4):e18642. doi: 10.5812/ijem.18642.

Abstract
Copyright: Copyright © 2014, International Journal of Endocrinology and Metabolism. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Method
4. Results
5. Discussion
Footnotes
References
  • 1. Carmina E, Lobo RA. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab. 1999; 84(6): 1897-9[DOI][PubMed]
  • 2. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004; 89(6): 2745-9[DOI][PubMed]
  • 3. Rotterdam EA-SPCWG. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004; 81(1): 19-25[PubMed]
  • 4. Shroff R, Syrop CH, Davis W, Van Voorhis BJ, Dokras A. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria. Fertil Steril. 2007; 88(5): 1389-95[DOI][PubMed]
  • 5. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009; 91(2): 456-88[DOI][PubMed]
  • 6. Teng HW, Chien YW, Hsu MI, Chen CI. The relationship between carotid intima-media thickness and endogenous androgens in young women with polycystic ovary syndrome in Taiwan. Gynecol Endocrinol. 2013; 29(3): 238-41[DOI][PubMed]
  • 7. Koiou E, Tziomalos K, Katsikis I, Kalaitzakis E, Kandaraki EA, Tsourdi EA, et al. Circulating platelet-derived microparticles are elevated in women with polycystic ovary syndrome diagnosed with the 1990 criteria and correlate with serum testosterone levels. Eur J Endocrinol. 2011; 165(1): 63-8[DOI][PubMed]
  • 8. Christakou CD, Diamanti-Kandarakis E. Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome. Womens Health (Lond Engl). 2008; 4(6): 583-94[DOI][PubMed]
  • 9. Book CB, Dunaif A. Selective insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 1999; 84(9): 3110-6[DOI][PubMed]
  • 10. Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JM, Sattar N. Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2001; 86(6): 2453-5[DOI][PubMed]
  • 11. Paradisi G, Steinberg HO, Hempfling A, Cronin J, Hook G, Shepard MK, et al. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation. 2001; 103(10): 1410-5[PubMed]
  • 12. Orio F, Jr, Palomba S, Cascella T, De Simone B, Di Biase S, Russo T, et al. Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004; 89(9): 4588-93[DOI][PubMed]
  • 13. Gonzalez F, Rote NS, Minium J, Kirwan JP. Evidence of proatherogenic inflammation in polycystic ovary syndrome. Metabolism. 2009; 58(7): 954-62[DOI][PubMed]
  • 14. Vizioli L, Muscari S, Muscari A. The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract. 2009; 63(10): 1509-15[DOI][PubMed]
  • 15. Coban E, Ozdogan M, Yazicioglu G, Akcit F. The mean platelet volume in patients with obesity. Int J Clin Pract. 2005; 59(8): 981-2[DOI][PubMed]
  • 16. Kodiatte TA, Manikyam UK, Rao SB, Jagadish TM, Reddy M, Lingaiah HKM, et al. Mean platelet volume in Type 2 diabetes mellitus. J Lab Physicians. 2012; 4(1): 5[DOI]
  • 17. Tavil Y, Sen N, Yazici HU, Hizal F, Abaci A, Cengel A. Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Thromb Res. 2007; 120(2): 245-50[DOI][PubMed]
  • 18. Nechita A, Delcea C, Enache V, Ploesteanu RL, Cazacu C, Andronescu AM, et al. Metabolic syndrome and mean platelet volume variation in patients with chest pain and negative cardiac enzymes. J Med Life. 2013; 6(2): 156-60[PubMed]
  • 19. Bath P, Algert C, Chapman N, Neal B, Progress Collaborative Group . Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke. 2004; 35(3): 622-6[DOI][PubMed]
  • 20. Kebapcilar L, Taner CE, Kebapcilar AG, Sari I. High mean platelet volume, low-grade systemic coagulation and fibrinolytic activation are associated with androgen and insulin levels in polycystic ovary syndrome. Arch Gynecol Obstet. 2009; 280(2): 187-93[DOI][PubMed]
  • 21. Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 1981; 140(7): 815-30[PubMed]
  • 22. Rosenfield RL. Clinical review: Identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab. 2007; 92(3): 787-96[DOI][PubMed]
  • 23. Silfeler DB, Kurt RK, Yengil E, Un B, Arica S, Baloglu A. Evaluation of Mean Platelet Volume values in lean women with polycystic ovary syndrome. Pak J Med Sci. 2014; 30(3): 589-92[DOI][PubMed]
  • 24. Nisenblat V, Norman RJ. Androgens and polycystic ovary syndrome. Curr Opin Endocrinol Diabetes Obes. 2009; 16(3): 224-31[DOI][PubMed]
  • 25. Alemzadeh R, Kichler J, Calhoun M. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome. Eur J Endocrinol. 2010; 162(6): 1093-9[DOI][PubMed]
  • 26. Gonzalez F, Sia CL, Bearson DM, Blair HE. Hyperandrogenism induces a proinflammatory TNFalpha response to glucose ingestion in a receptor-dependent fashion. J Clin Endocrinol Metab. 2014; 99(5)-54[DOI][PubMed]
  • 27. Castelo-Branco C, Steinvarcel F, Osorio A, Ros C, Balasch J. Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism. Gynecol Endocrinol. 2010; 26(10): 736-42[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader